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Roughly one-third of the human lifetime is spent in sleep, yet the reason for sleep
remains unclear. Understanding the physiologic function of sleep is crucial toward
establishing optimal health. Several proposed concepts address different aspects of
sleep physiology, including humoral and circuit-based theories of sleep-wake regulation,
the homeostatic two-process model of sleep regulation, the theory of sleep as a
state of adaptive inactivity, and observations that arousal state and sleep homeostasis
can be dissociated in pathologic disorders. Currently, there is no model that places
the regulation of arousal and sleep homeostasis in a unified conceptual framework.
Adenosine is well known as a somnogenic substance that affects normal sleep-wake
patterns through several mechanisms in various brain locations via A1 or A2A receptors
(A1Rs or A2ARs). Many cells and processes appear to play a role in modulating the
extracellular concentration of adenosine at neuronal A1R or A2AR sites. Emerging
evidence suggests that A1Rs and A2ARs have different roles in the regulation of sleep.
In this review, we propose a model in which A2ARs allow the brain to sleep, i.e., these
receptors provide sleep gating, whereas A1Rs modulate the function of sleep, i.e., these
receptors are essential for the expression and resolution of sleep need. In this model,
sleep is considered a brain state established in the absence of arousing inputs.
Keywords: adenosine, slow-wave sleep, A2A receptor, A1 receptor, slow-wave activity, sleep homeostasis,
dopamine, motivation
INTRODUCTION
Sleep is a highly conserved behavior that is vital to survival among all living organisms with a
nervous system, from worms to humans. Chronic sleep loss is linked to a wide range of deleterious
physiologic changes, such as altered food intake, weight loss or gain, skin lesions, compromised
thermoregulation, and even death (Rechtschaffen et al., 1989; Siegel, 2008). Humans spend roughly
one-third of their lives asleep. While we know why we eat, drink, and mate, we do not yet know
why we sleep. The neuroscience community has therefore increased efforts to gain knowledge of
the physiologic function of sleep.
During sleep, cortical neurons alternate between periods of firing and periods of silence. The
switching between the two states, also known as ON and OFF states, is widely synchronized across
neurons and represented by slow wave activity (SWA) in encephalography. SWA is observed
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as slow, oscillatory neocortical activity (0.5–4.5 Hz) that
intensifies in correlation with wake duration and declines during
sleep, but is expressed only during slow wave sleep (SWS).
Because SWS-SWA increases as sleep loss is prolonged and
decreases as sleep progresses, it is widely used as a marker
of mammalian sleep homeostasis. The rates of SWA build-
up and decay can be altered by extreme sleep loss or by
pharmacologic or genetic manipulations in mammals, especially
those affecting adenosine systems of the central nervous system
(CNS). The adenosine system can also affect the gating of
SWS-SWA expression by modulating the arousal level, thereby
altering the duration of time during which sleep homeostasis and
function can occur.
Adenosine is the key building block of every cell’s energy
source, i.e., adenosine triphosphate (ATP), and the related
adenosine mono- and di-phosphates (AMP and ADP,
respectively). Adenosine fulfills a wide range of physiologic
and pathophysiologic functions (Fredholm, 2014). In the
nervous system, adenosine acts as a neuromodulator through
metabotropic receptors. Although adenosine acts on four
evolutionarily well-conserved receptors present on most cells, it
is believed to modulate sleep need and arousal by acting through
A1 and A2A receptors (A1Rs and A2ARs), respectively.
In light of the emerging roles of adenosine and its receptors in
regulating different aspects of sleep, we propose a model for the
gating and function of sleep. In our model, A2ARs allow the brain
to sleep, i.e., these receptors provide sleep gating, whereas A1Rs
modulate the function of sleep, i.e., these receptors are essential
for the expression and resolution of the sleep need.
ASPECTS OF SLEEP/WAKE
REGULATION
Humoral Theory of Sleep-Wake
Regulation
The humoral theory of sleep-wake regulation posits that during
wakefulness, one or more endogenous somnogenic factors
is produced and accumulated. Brain activity decreases when
the concentration of somnogenic substances increases to a
certain threshold. These substances are gradually metabolized
during sleep, which leads to a return to the waking state.
Rosenbaum (1892) hypothesized that sleep is regulated
by humoral factors; i.e., excess water accumulation due
to oxidative processes in nerve cells during wakefulness
depresses neuronal excitability and removal of the excess
water during sleep restores full brain activity, resulting in
wakefulness. A few years later, Ishimori (1909) and Legendre
and Pieron (1913) independently demonstrated the existence
of sleep-promoting hypnogenic substances, also known as
“hypnotoxins,” in the cerebrospinal fluid of sleep-deprived dogs
(Kubota, 1989; Inoué et al., 1995).
The hypnotic effect of adenosine in the mammalian brain was
discovered in 1954 (Feldberg and Sherwood, 1954). Adenosine
as a neuromodulator with somnogenic properties should thus
be classified as a sleep substance. Extensive evidence also
suggests that components of the immune system, such as pro-
inflammatory cytokines (Krueger et al., 1984, 2001; Mullington
et al., 2000, 2001; Krueger and Majde, 2003) [for review, see
(Krueger et al., 2011)] and prostaglandins (Ushikubi et al., 1998;
Lazarus et al., 2007; Urade and Lazarus, 2013; Oishi et al., 2015)
[for review, see (Urade and Lazarus, 2013)], are interrelated
with the regulation of sleep. The involvement of other putative
hypnogenic substances, including anandamide (Garcia-Garcia
et al., 2009), urotensin-II peptide (Huitron-Resendiz et al., 2005),
and the Drosophila peptide NEMURI (Toda et al., 2019), is also
implicated in the sleep process.
Circuit-Based Theories of Sleep-Wake
Regulation
A slow humoral process, however, cannot sufficiently explain
the reversibility of sleep, especially rapid transitions from sleep
to wake in response to external stimuli. Experimental work by
Constantin von Economo in the early 20th century produced
findings that inspired circuit-based theories of sleep/wake
regulation. In 1916, von Economo began to see patients
with a new type of encephalitis eventually referred to as
encephalitis lethargica or von Economo’s sleeping sickness.
The disorder was characterized by lesions in the anterior
hypothalamus leading to prolonged insomnia or lesions at
the junction of the brainstem and forebrain leading to
prolonged sleepiness (von Economo, 1917; Economo, 1930). Von
Economo concluded that these brain areas must play a role in
sleep/wake regulation. The “passive theory,” which dominated
in the 1940/1950s, suggested that sleep occurs passively due
to decreased activity of the brainstem reticular formation
(Bremer, 1938; Moruzzi and Magoun, 1949). Importantly,
this “passive theory” implicates a necessary active neuronal
modulation to maintain a behavioral state of wake via the
ascending reticular activating system. Although overly restrictive
to the reticular activating system with regard to the wake-
modulatory components, the principle of a necessary activation
for wake cannot be ruled out; nor can an active sleep-promoting
modulation be ruled out, as these are not mutually exclusive
types of modulation.
Many decades later, neurons that are active when animals
sleep were identified in the ventrolateral preoptic area (VLPO)
near the third ventricle in the anterior part of the hypothalamus
(Sherin et al., 1996; Chung et al., 2017). Studies demonstrated that
sleep is promoted by projections from the GABAergic preoptic
area (POA), including the VLPO, to the tuberomammillary
nucleus (TMN) in the posterior hypothalamus (Sherin et al.,
1998; Chung et al., 2017), which contains neurons that produce
histamine, a neurotransmitter having an important role in
arousal (Huang et al., 2006; Haas et al., 2008; Oishi et al., 2008).
These findings provided strong evidence of sleep control by the
POA-TMN neural pathway.
Neural circuits in the brainstem and basal ganglia also regulate
sleep/wake behavior. The parafacial zone (PZ) in the medulla
contains sleep-promoting GABAergic neurons (Anaclet et al.,
2012, 2014) that project to the parabrachial nucleus (PB), a critical
nucleus for cortical activation as lesions of the PB result in a
comatose state (Fuller et al., 2011).
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More recently, the involvement of dopaminergic neurons in
the ventral tegmental area (VTA) was strongly implicated in
the arousal effect (Eban-Rothschild et al., 2016; Oishi et al.,
2017a). A role for dopamine in arousal is also supported
by evidence that amphetamine, which induces the release of
monoamines (including dopamine), increases alertness and
psychomotor performance in sleep-deprived individuals (Bonnet
et al., 2005). Dopamine transporters are necessary for the
wake-promoting effects of amphetamine (Wisor et al., 2001).
Ablating or suppressing GABAergic neurons in the ventral
medial midbrain/pons (VMP), including the VTA, produces
wakefulness and prevents sleep mainly through dopaminergic
systems (Takata et al., 2018; Yu et al., 2019). Furthermore,
the ability of dopamine neurons in the VTA to promote
wakefulness is at least in part mediated by projections to the
nucleus accumbens (NAc; Eban-Rothschild et al., 2016). Medium
spiny GABAergic neurons in the NAc can be divided into two
groups that respond differentially to stimulation by dopamine or
adenosine. Direct pathway neurons express excitatory dopamine
D1 receptors and inhibitory adenosine A1Rs, whereas neurons of
the indirect pathway express inhibitory dopamine D2 receptors
and excitatory A2ARs. In fact, recent studies showed that NAc
direct pathway neurons induce wakefulness (Luo et al., 2018)
and A2AR-expressing indirect pathway neurons strongly induce
SWS (Oishi et al., 2017b). The indirect pathway neurons in
the NAc produce sleep by inhibiting the ventral pallidum
(VP) in the basal forebrain (BF), although these neurons
also have sparse to moderate projections to other well-known
arousal-promoting areas, such as the lateral hypothalamus,
which produces orexin, the TMN, and the VTA. Interestingly,
chemogenetic activation of the BF, including the VP, largely
reduces sleep (Anaclet et al., 2015).
Altogether, it is impossible to abolish sleep completely by
lesioning the afore-mentioned inhibitory circuits, including the
POA-TMN, PZ-PB, and NAc-VP pathways, making it unlikely
that the regulation of sleep time depends on a single center
(i.e., a master switch for sleep in the brain may not exist). On
the contrary, the existence of various neural circuits controlling
sleep suggests that sleep is gated by different processes. All
of these sleep/wake circuits clearly modulate an animal’s level
of arousal (i.e., vigilance) to determine the behavioral state
and GABA is the key neurotransmitter for promoting the
transition from wake to sleep and the duration of sleep. For
example, the observation that the level of wakefulness is regulated
by VMP GABAergic neurons (Takata et al., 2018) indicates
the ability of the brain to adapt an animal’s sleep/wake time
to its behavior.
The transition from waking to sleep may be essential,
at least under physiologic conditions, for the facilitation of
sleep function to occur. A sufficiently increased level of
arousal, as may be experimentally or environmentally induced,
prevents sleep occurrence and, accordingly, sleep function.
The resulting increase in sleep need is normally reflected by
an increase in SWA in the ensuing sleep episode. During
this ensuing episode, SWS-SWA resolves toward a non-sleep
deprived baseline and the threshold for arousal to waking
decreases. As a matter of fact, local sleep, i.e., a phenomenon
in which discrete regions of cortical neurons go “oﬄine”
similar to during sleep, but other regions do not, is insufficient
for sleep function to occur (Vyazovskiy et al., 2011), most
likely as a result of the brain’s massive interconnectivity.
Thus the integration of local sleep events into a global
sleep state is necessary for effective sleep function, even
at a local level.
Homeostatic Regulation of Sleep
(Two-Process Model)
In 1982, Alexander Borbély at the University of Zürich in
Switzerland proposed a two-process model of sleep regulation
(Borbély, 1982) that currently prevails as a major conceptual
framework in sleep research. In a simplified version of the
two-process model of sleep regulation, sleep propensities
in homeostatic and circadian processes are commonly
plotted against the time of day and interactions of the two
processes determine the cardinal aspects of sleep regulation.
The “homeostatic” process is controlled by the sleep pressure
or need that builds up during the waking period and dissipates
during sleep. In contrast, the “circadian” process, i.e., the
sleep/wake cycle during the day and night, is controlled by a
circadian pacemaker or biologic clock. Although it was originally
hypothesized that the circadian process is independent of
prior sleep and waking, experiments in mice lacking clock
genes revealed that clock gene knockout (KO) disrupts not
only circadian processes, but also sleep homeostatic processes
(Franken, 2013). This suggests overlapping functions for the
circadian genes in sleep homeostatic control.
Consistent with the two-process model, a homeostatic
response to sleep loss, namely sleep rebound in an animal
after sleep deprivation, is considered an essential criterion of
sleep. Rebound can reflect an increase in SWS-SWA power
and/or an increase in SWS duration along with an increase in
consolidation. Of these two rebound parameters, SWS-SWA is
better correlated with prior waking time. Although a rebound
increase in SWA during SWS is often associated with an increase
in SWS time or consolidation, its occurrence may be dissociated
from an effect on sleep time (Douglas et al., 2007; Bjorness et al.,
2009; Suzuki et al., 2013). Importantly, SWA during SWS is
considered to be an indicator of sleep intensity (Borbély and
Neuhaus, 1979), providing a dimension beyond time in the
recovery from prolonged waking. Interestingly, although sleep
rebound is widely observed after sleep loss, some species skip
sleep in favor of migration, mating, or other social interactions
and do not catch up on lost sleep (Berger and Phillips, 1994;
Rattenborg et al., 2004; Lyamin et al., 2005; Fuchs et al., 2009;
Thimgan et al., 2010; Lesku et al., 2012). Recently, scientists
at the Imperial College London demonstrated that male flies
in the presence of another male fly undergo sleep loss that
results in a sleep rebound once the male intruder is removed,
whereas a resident fly also loses sleep in the presence of
a female fly, but shows no sleep rebound when the female
fly is removed (Beckwith et al., 2017), suggesting that sexual
arousal in flies prevents a homeostatic response to sleep loss.
Altogether, there is ample evidence in nature challenging the
view that sleep rebound is an inescapable outcome of sleep
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loss. Nevertheless, the “rebound” in these cases refers only to
sleep duration and not to SWS-SWA intensity. This potential
dissociation of SWS duration from SWS-SWA expression (i.e.,
SWS duration may not reflect the SWA changes shaping sleep
homeostasis) suggests that it may not be possible to fully interpret
rebound sleep or the lack thereof in the absence of SWS-
SWA assessment.
Another limitation of the two-process model is that it defines
circadian input as the only allostatic component that drives the
balance between waking and sleep. Sleep/wake behavior is also
influenced by cognitive and emotional factors (Saper et al., 2005;
Fernandez-Mendoza et al., 2014; Mullins et al., 2014) or other
basic drives, such as a lack of food, predator confrontation,
mating pressure, and seasonal migration (Yamanaka et al., 2003;
Cano et al., 2008). The mechanisms by which motivational
stimuli or stressors interact with sleep/wake behavior are
not easily accounted for by the two-process model. On the
other hand, if the exceptional conditions mentioned above
primarily affect arousal level and thus gating of sleep, then sleep
homeostasis, conceptualized as “process S” in the two-process
model, may still occur. Sleep homeostasis, although related to
arousal (sleep need can dissipate to the largest extent only during
sleep) appears to follow an exponential rate of decay (Franken
et al., 2001; Bjorness et al., 2016). With greater sleep need,
there is greater rebound SWS-SWA, but the rate of decay is
slowed, further enhancing the amount of SWS-SWA expressed
(Bjorness et al., 2016).
The increased sleep duration and consolidation associated
with increased sleep need may reflect a decreased level of arousal
needed for waking although both external sensory input as well as
the internal state (likely to include circadian drive, need for food,
predator threat, sex drive, etc.) remain as effective determinants.
Accordingly, level of arousal and sleep duration are dynamic,
relying on the integration of multiple factors in addition to
previous waking time.
Sleep as a State of Adaptive Inactivity
An alternative view proposes that sleep enforces adaptive
inactivity to conserve energy when activity is not beneficial
(Siegel, 2009). The wide variability in sleep duration across
the animal kingdom (Preston et al., 2009) suggests the sleep
amount of an animal may be adapted to the species’ behavior
that is critical for survival. Consequently, animals may have
the ability to dispense with sleep when varying ecologic
demands favor wakefulness; e.g., the ability of male pectoral
sandpipers to maintain high neurobehavioral performance
despite greatly reduced sleeping time when competing for
mating opportunities in a short annual window of female
fertility (Lesku et al., 2012) may contradict the notion that
decreased performance is an inescapable outcome of sleep
loss. A model of sleep as a state of adaptive inactivity
challenges the hypothesis that the sleep state persists because
it has a vital physiologic function and proposes that sleep
has not evolved for what happens when we are asleep, but
rather for the energy-saving absence of activity during sleep.
The magnitude of energy savings gained through sleep is
still unknown, although a new framework for determining
relative energy savings during sleep was recently described
(Schmidt et al., 2017).
The teleological problem of sleep function may arise from
the presumption of sleep’s evolution from a default state of
waking. Humans are likely biased toward this presumption
by the egocentricity of waking consciousness. The adaptive
inactivity model could be modified by reorientation of the
question “why do we sleep” to “why do we wake?” In this
model, sleep is considered the state that facilitates vegetative
functions like anabolism and replacement of proteins, complex
carbohydrates, and complex lipids and organelles. The vegetative
functions are clearly not inactivity or passive in terms of
energy conservation. On the contrary, there is evidence for
increased energy utilization in sleep, such as ATP mobilization
and AMP dephosphorylation (Dworak et al., 2010). Moreover,
the cellular metabolism of brain tissue does not coincide with
the systemic eating and digestion of food. From this perspective,
an organism is driven to waking primarily by non-vegetative,
life-essential pursuits, such as foraging for food, avoiding
predators, and, occasionally, sex, along with an integrated
circadian timer (also controlling arousal). This model is thus
consistent with an active drive or activating system needed
to maintain wake.
Dissociation of the Arousal State and
Sleep Homeostasis
An increase in the response threshold to external stimuli is a
core feature of sleep (Zepelin, 1994) and is critical for defining
sleep in animals that lack a cortex (for review, see Ho and
Sehgal, 2005). Prolonged waking by sleep deprivation increases
the arousal threshold during subsequent sleep (Williams et al.,
1964; Bonnet, 1985), and stronger stimuli are necessary to
prevent sleeping/prolong waking (Blumberg et al., 2004). As
with spontaneous waking, arousal during sleep deprivation
is modulated by internal and external stimuli, but within
the context of sleep deprivation the arousal threshold is
typically increased. Arousal-related brain regions show greater
activity, as measured by c-fos, under sleep deprivation mediated
by exposure to novel environments or social interaction
compared with gentle handling alone (Deurveilher et al.,
2013). Furthermore, the nature of the homeostatic response
to prolonged waking varies across development with increases
in sleep time preceding the appearance of increased SWA
power (Frank et al., 1998). Finally, SWA power, commonly
used as an indicator of homeostatic sleep need, is increased
within waking during prolonged sleep deprivation (Franken
et al., 2001; Vyazovskiy et al., 2011), but the relationship
between SWA and sleep homeostasis can be dissociated in
pathologic disorders. SWA power is increased during waking
and rapid eye movement (REM) sleep in Alzheimer’s disease
(Hassainia et al., 1997; Jeong, 2004); whereas SWA is increased
during waking but decreased during sleep in schizophrenia
(Keshavan et al., 1998; Hoffmann et al., 2000; Fehr et al.,
2003). Conversely, faster EEG activity, such as beta and gamma
rhythms commonly used as an indicator of arousal, is high
during sleep in a subset of insomniacs (Perlis et al., 2001;
Dolsen et al., 2017).
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ADENOSINE AND SLEEP
Adenosine Metabolism and Levels
During Sleep and Wakefulness
Hydrolysis of AMP and S-adenosylhomocysteine (SAH)
produces adenosine (Schrader, 1983; Fredholm, 2007).
Adenosine is generated from SAH by SAH hydrolase, which also
acts to trap adenosine in the presence of excess L-homocysteine.
This takes place intracellularly and the bidirectional actions
of the enzyme ensure the constant presence of a particular
concentration of adenosine in the cell. Whether SAH hydrolase
is involved in generating adenosine in the brain, however, is
controversial (Latini and Pedata, 2001). Adenosine is formed
intracellularly and extracellularly from 5′-AMP by different
5′-nucleotidase (5′-NT) (Zimmermann, 2000). A cascade
of actions by an ecto-5′-NT, together with ecto-ATPases,
terminates the action of ATP as extracellular signaling molecules
(Zimmermann, 2000, 2006; Yegutkin, 2008; Kovacs et al., 2013).
High adenosine levels are reduced by the actions of adenosine
deaminase (ADA), or are taken up by cells where adenosine
is rapidly phosphorylated to AMP by adenosine kinase (AdK),
an enzyme that effectively controls the intracellular adenosine
concentration (Figure 1; Fredholm et al., 2005; Oishi et al.,
2008; Parkinson et al., 2011). Importantly, AdK binds a molecule
of ATP and adenosine, catalyzes the transfer of a phosphate
group from ATP to adenosine and produces ADP and AMP.
As a result, the rate of adenosine metabolism is reflected by
the [ATP]/[ADP][AMP] ratio, linking the rate of adenosine
metabolism to the metabolic state of the cell. In the adult CNS,
AdK expression occurs predominately in the glia (Studer et al.,
2006), and thus the concentration of adenosine is controlled by
the metabolic state of the glia.
Bi-directional equilibrative nucleoside transporters regulate
the concentration of adenosine available to cell surface adenosine
receptors (Parkinson et al., 2011; Dos Santos-Rodrigues et al.,
2014). Therefore, adenosine levels are dependent on the
formation and removal of extracellular adenosine. Extracellular
adenosine levels are low under basal conditions – approximately
30 to 300 nM (Ballarin et al., 1991), but may exceed 1 µM under
more extreme conditions, such as mild hypoxia or strenuous
exercise, and can reach up to several tens of micromolar
concentration in severely traumatic situations, including local
ischemia (Fredholm, 2007).
Adenosine triphosphate depletion and an increase of
extracellular adenosine levels are positively correlated
(Kalinchuk et al., 2003) and positively associated with sleep
(Rainnie et al., 1994; Porkka-Heiskanen et al., 1997). Thus,
adenosine may represent a state of relative energy deficiency.
During spontaneous sleep/wake behavior in cats, adenosine
levels in several brain regions are higher during SWS than
wakefulness (Porkka-Heiskanen et al., 1997, 2000). Moreover,
in vivo microdialysis studies in cats revealed that adenosine
concentrations increase 2-fold in the BF during a prolonged
6-h period of wakefulness compared with that at the beginning
of sleep deprivation. Under more chronic sleep deprivation
protocols, however, increases in adenosine concentrations
during prolonged waking are no longer observed (Clasadonte
et al., 2014), suggesting that loss of the adenosine response
may mark a shift from a homeostatic response to an allostatic
response following reduced sleep.
Six decades after the discovery of adenosine’s role in
sleep, the mammalian brain cell types involved in the sleep-
promoting effects of adenosine remain unclear (Feldberg and
Sherwood, 1954). ATP, which is rapidly degraded to adenosine,
and adenosine are released from glial cells and neurons. In
genetically engineered mice in which the release of ATP is non-
specifically blocked in astrocytes by selective expression of a
dominant negative SNARE domain, decreased concentrations of
extracellular adenosine are observed (Pascual et al., 2005). While
the amounts of wakefulness, SWS, and REM sleep in these mice
are indistinguishable from those in wild-type mice, these mice
exhibit reduced SWA and recovery sleep after sleep deprivation
(Halassa et al., 2009). Furthermore, reducing AdK in astrocytes,
thereby increasing the adenosine tone, is sufficient to increase
SWS-SWA and sleep consolidation, reduce the decrease in SWA
across the light phase, and slow the decay of SWS-SWA within
an average SWS episode, whereas selectively reducing AdK in
neurons has no effect (Bjorness et al., 2016). These observations
suggest that adenosine mediates the sleep deprivation-induced
homeostatic sleep response. The source of the released adenosine,
however, remains controversial. Some of the adenosine may
originate from astrocytes and the majority may originate from
neurons, but direct proof is lacking and thus the exact source
of adenosine remains unknown. On the other hand, control of
extracellular adenosine modulating sleep need clearly involves
glial metabolism mediated by AdK (Bjorness et al., 2016).
Radulovacki et al. (1983) extensively investigated the effects
of adenosine on wakefulness. They found that increasing the
levels of adenosine in the central nervous system of rats by
systemic administration of the ADA inhibitor deoxycoformycin
led to increases in REM and SWS. In addition, Oishi et al.
(2008) reported that focal administration of the ADA inhibitor
coformycin into the rat TMN, where ADA is dominantly
expressed, increases SWS, further supporting a hypnotic
role for adenosine.
Effects of A1 Receptors and Sleep
Homeostasis
Adenosine acting through A1Rs facilitates sleep as non-selective
and selective A1R agonists increase sleep and SWA (Radulovacki
et al., 1984; Benington et al., 1995), whereas A1R antagonists
decrease sleep and SWA (Virus et al., 1990; Methippara et al.,
2005; Thakkar et al., 2008). Furthermore, A1R antagonism
within the BF reduces the homeostatic sleep and SWA response
following acute sleep deprivation (Gass et al., 2009). Conditional
KO of A1Rs predominantly affecting forebrain glutamatergic
neurons prevents sleep deprivation-induced increases in SWA,
indicating that A1Rs are necessary for normal sleep homeostasis
(Bjorness et al., 2009). In mixed background mice with
constitutive KO of A1Rs, the normal sleep homeostatic response
is maintained as measured by slow wave energy [SWE;
SWA (0.5–4.5 Hz) × time] in SWS (Stenberg et al., 2003).
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FIGURE 1 | Control of the adenosine concentration by the metabolic state of astrocytes. Adenosine taken up by astrocytes is rapidly phosphorylated to AMP by
adenosine kinase (AdK), an enzyme expressed predominantly in glia in the adult CNS. AdK effectively controls the intracellular adenosine concentration by catalyzing
the transfer of a phosphate group from ATP to adenosine to produce ADP and AMP. As a result, the rate of adenosine metabolism is reflected by the
[ATP]/[ADP][AMP] ratio, linking the rate of adenosine metabolism to the metabolic state of the cell. Equilibrative nucleoside transporters (ENT) bi-directionally regulate
the concentration of adenosine available to pre- and post-synaptic A1Rs and A2ARs. Other abbreviations used: 5′-NT, 5′-nucleotidase; ADA, adenosine deaminase.
Further, acute application of a selective A1R antagonist blocks the
homeostatic response of increased SWS-SWA in sleep-deprived
wild-type mice, but is ineffective in the constitutive KO mice
under the same conditions (Stenberg et al., 2003). This finding
suggests the presence of compensatory mechanisms in mice with
constitutive KO that were not present in mice with conditional
KO. Sleep facilitation via A1Rs occurs through inhibition of
wake-active neurons in several brain areas, including both the
brainstem and forebrain regions of the cholinergic arousal system
[mesopontine tegmentum (Rainnie et al., 1994) and BF (Alam
et al., 1999; Thakkar et al., 2003)], and the lateral hypothalamus
containing hypocretin/orexin neurons (Liu and Gao, 2007).
Additionally, administration of a selective A1R agonist into the
TMN decreases histamine in the frontal cortex while increasing
sleep and SWA (Oishi et al., 2008), suggesting that adenosine
also inhibits activity of this wake-promoting neurotransmitter
system. An additional mechanism by which adenosine facilitates
sleep through A1Rs is by disinhibiting sleep-active neurons
in the VLPO and anterior hypothalamic area (Chamberlin
et al., 2003; Morairty et al., 2004). Finally, A1Rs mediate
homeostatic sleep pressure based on astrocytic gliotransmission
(Halassa et al., 2009) and as part of a glial-neuronal circuit
(Bjorness et al., 2016).
Prolonged waking through sleep deprivation increases
the expression of A1Rs in both humans and rodents
(Basheer et al., 2007; Elmenhorst et al., 2007), with
expression levels normalizing after recovery sleep in humans
(Elmenhorst et al., 2017).
As mentioned above, SWA power is the primary indicator of
homeostatic sleep need. SWA power reflects both the number
of cells firing at SWA frequencies, which is an intrinsic
feature of thalamocortical neurons (McCormick and Pape, 1990;
Dossi et al., 1992), and the synchronicity of firing across
neurons, which is a circuit effect involving cortical neurons,
thalamocortical neurons, and neurons of the reticular nucleus
of the thalamus (Steriade et al., 1993). Activation of A1Rs
influences SWA by both direct and indirect mechanisms; the
direct mechanism is based on presynaptic inhibition of cortical
and thalamic neurons, which results in relative functional
deafferentation along with an A1R-induced increase in whole
cell, GIRK channel conductance and decreased hyperpolarization
activated currents (Ih), such that adenosine enhances slow
oscillations in thalamocortical neurons (Pape, 1992). The
indirect mechanism is a reduction of cholinergic tone by A1R-
mediated inhibition of cholinergic arousal neurons (Rainnie
et al., 1994; Porkka-Heiskanen et al., 1997). Acetylcholine
inhibits slow oscillation in thalamocortical neurons (Curro
Dossi et al., 1991; Steriade et al., 1991; McCormick, 1993);
thus reduction of cholinergic tone is permissive for the
expression of SWA.
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Effects of A2A Receptors and Control of
Arousal
Infusion of the selective A2AR agonist CGS21680 into the
subarachnoid space below the ventral surface region of the
rostral BF in rats or into the lateral ventricle of mice produces
robust increases in SWS and REM sleep (Satoh et al., 1996;
Urade et al., 2003). In vivo microdialysis experiments, infusing
CGS21680 into the BF dose-dependently decreases histamine
release in the frontal cortex and medial preoptic area, and
increases the release of GABA in the TMN, but not in the
frontal cortex (Hong et al., 2005). Infusion of the GABA
antagonist picrotoxin into the TMN attenuates the CGS21680-
induced inhibition of histamine release, suggesting that the A2AR
agonist induces sleep by inhibiting the histaminergic system
through increasing the release of GABA in the TMN. Intracellular
recordings of VLPO neurons in rat brain slices demonstrated
that two distinct types of VLPO neurons exist in terms of
their responses to serotonin and adenosine. VLPO neurons are
inhibited by noradrenaline, acetylcholine, and an A1R agonist,
whereas serotonin inhibits type-1 neurons, but excites type-2
neurons. An A2AR agonist post-synaptically excites type-2, but
not type-1, neurons. These findings suggest that type-2 neurons
are involved in initiating sleep, whereas type-1 neurons may
contribute to sleep consolidation, because they are only activated
in the absence of inhibitory effects from wake-inducing systems
(Gallopin et al., 2005).
Administration of CGS21680 into the rostral BF, however,
produces c-fos expression not only in the VLPO, but also within
the NAc shell and the medial portion of the olfactory tubercle
(Satoh et al., 1999; Scammell et al., 2001). Direct infusion of
the A2AR agonist into the NAc induces SWS that corresponds
to approximately 75% of the sleep amount measured when the
A2AR agonist is infused into the subarachnoid space (Satoh
et al., 1999). This observation may indicate that activating A2ARs
within or close to the NAc induces sleep. Acting opposite
to adenosine, caffeine, which is the most widely consumed
psychostimulant in the world, enhances wakefulness because
it acts to antagonize both A1R and A2AR subtypes. At doses
commonly consumed by humans, caffeine partially (estimated
as 25–50%) and non-selectively (similar affinity for both A1Rs
and A2ARs) blocks adenosine receptors (Fredholm et al., 1999).
Experiments using mice with global genetic A1R and A2AR KO
revealed that A2ARs, but not A1Rs, mediate the wakefulness-
inducing effect of caffeine (Huang et al., 2005), while single
nucleotide mutations of the A2AR gene confer sensitivity to
caffeine and sleep deprivation (Bodenmann et al., 2012). The
specific role of A2ARs in the striatum was investigated in
conditional A2AR KO mice based on the Cre/lox technology and
local infection with AAV carrying short-hairpin RNA of the A2AR
to silence the expression of the receptor. Selective deletion of
the A2ARs in the NAc shell blocked caffeine-induced wakefulness
(Lazarus et al., 2011).
For caffeine to be effective as an A2AR antagonist, adenosine
must tonically activate excitatory A2ARs within the NAc
shell. This activation likely occurs in the NAc shell because
A2ARs are abundantly expressed throughout the striatum,
FIGURE 2 | Adenosine receptors influence sleep/wake behavior by
modulating the arousal level through A2ARs or A1Rs and the sleep need
through A1Rs. Increased activity of the arousal centers promotes
wakefulness. For example, activation of A2ARs in the nucleus accumbens
(NAc) and hypothalamus facilitates sleep through the inhibition of
arousal-promoting neurons. The duration of wake time positively correlates
with sleep need and the buildup of extracellular adenosine. The buildup of
adenosine in the cortex and thalamus increases SWS-SWA through the
activation of A1Rs. Sleep need also increases the probability of a state change
from wake to sleep, primarily by decreasing arousal center activity (in part by
activating A1Rs in arousal centers and A2ARs in the NAc). The sleep state is
permissive for sleep function that resolves the sleep need (as sleep function is
accomplished), as reflected by the resolution of rebound SWS-SWA.
including the NAc shell and sufficient levels of adenosine
are available under basal conditions (Rosin et al., 1998;
Svenningsson et al., 1999). A recent study showed that
chemogenetic or optogenetic activation of NAc A2AR core
neurons projecting to the VP in the BF strongly induces
SWS, whereas chemogenetic inhibition of these neurons
prevents sleep induction, but does not affect homoeostatic
sleep rebound (Oishi et al., 2017b). Interestingly, motivational
stimuli suppress sleep and inhibit the activity of VP-projecting
NAc A2AR neurons. In addition, another recent study revealed
that adenosine is a plausible candidate molecule for activating
NAc core A2AR neurons to induce SWS because elevated
adenosine levels in the NAc core promote SWS via A2ARs
(Zhou et al., 2019).
The sleep-gating ability of the NAc indirect pathway may
explain the tendency toward falling asleep in boring situations.
Interestingly, excessive daytime sleepiness is common in children
with attention-deficit/hyperactivity disorder, who frequently
start napping or daydream when they are bored (Weinberg
and Brumback, 1990). Dopamine produced by VTA neurons
has a key role in processing reward, aversive, or cognitive
signals (Wise, 2004; Bromberg-Martin et al., 2010; Schultz,
2015), and projections from VTA dopaminergic neurons to
the NAc, commonly known as the mesolimbic pathway,
constitute a well-characterized reward circuit in the brain
(Russo and Nestler, 2013; Volkow and Morales, 2015). Two
independent studies recently examined the contribution of VTA
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dopaminergic neurons to wakefulness under baseline conditions
by chemogenetic inhibition. One study found that chemogenetic
inhibition of VTA dopamine neurons decreases the amount of
wakefulness, thus suggesting that these neurons are necessary
for baseline wakefulness in mice (Eban-Rothschild et al., 2016).
The other study showed that chemogenetic inhibition of VTA
dopamine neurons does not significantly affect wakefulness at
baseline in mice (Oishi et al., 2017a). A plausible explanation for
the differences in the observations in these studies is different
ectopic Cre expression (Lammel et al., 2015) in the midbrain
of the tyrosine hydroxylase-Cre mice used by Eban-Rothschild
et al. (2016) or the dopamine transporter-Cre mice used by
Oishi et al. (2017a).
UNIFIED MODEL OF SLEEP-WAKE
REGULATION: GATING OF SLEEP
HOMEOSTASIS BY AROUSAL
As knowledge of the molecular and circuit bases of sleep/wake
regulation expands, new roles of adenosine receptors in
modulating different aspects of sleep emerge. For example,
A2ARs appear to promote sleep by suppressing arousal, whereas
sleep need and the response to sleep deprivation are mediated
by A1Rs, and these receptors may thus play a crucial role
in the function of sleep. In light of the dissociable effects of
adenosine for gating sleep and mediating sleep need at the
receptor level, we propose a model of sleep-wake regulation in
which the sleep state is regulated by arousal when an organism
must consolidate wakefulness in response to environmental
changes (Figure 2). A typical example is motivated behavior that
efficiently suppresses sleep of all stages and produces arousal
by utilizing mesolimbic dopaminergic systems, whereas the
wake state is suppressed in the absence of motivating stimuli
by activation of A2ARs in the NAc (Oishi and Lazarus, 2017;
Oishi et al., 2017b). The circadian and hypothalamic feeding
systems have indirect influences by driving internally generated
arousal, e.g., increasing motivation to forage according to the
circadian phase. Thus in the absence of motivating/external
arousing stimuli, the loss of the arousing influence of the
circadian system (the sleep phase) may be sufficient to allow
transition to sleep. On the other hand, sleep is necessary
for SWS-SWA to facilitate the expression of sleep need and
for the resolution of sleep need, a process in which A1Rs
play a crucial role.
CONCLUSION
Adenosine is a well-known somnogenic substance that
affects normal sleep-wake patterns. While the source of the
adenosine involved in sleep remains poorly understood, the
metabolism of adenosine in the CNS is significantly mediated
by adenosine kinase, which modulates the concentration
of adenosine at neuronal A1R sites. Similarly, adenosine
promotes sleep by several mechanisms in various locations via
A1Rs or A2ARs.
Adenosine receptor stimulation should be considered as a
potential treatment for insomnia. Insomnia is a sleep disorder
affecting millions of people around the world and frequently
co-occurs with a wide range of psychiatric disorders (Roth,
2007; de Zambotti et al., 2018; Seow et al., 2018). Although
A2AR agonists strongly induce sleep, classical A2AR agonists have
adverse cardiovascular effects and cannot be used clinically to
treat sleep disorders. Moreover, the development of adenosine
analogs for treating central nervous system disorders, including
insomnia, is hampered by the poor transport of these drugs across
the blood-brain barrier. A small blood brain barrier-permeable
monocarboxylate was recently demonstrated to induce sleep by
enhancing A2AR signaling in the brain, and surprisingly did
not exhibit the typical cardiovascular effects of A2AR agonists
(Korkutata et al., 2017). Therefore, molecules that allosterically
enhance A2AR signaling could help people with insomnia fall
asleep and may also be a potential treatment for psychiatric
illness. Similarly, molecules that enhance A1R signaling might
enhance sleep efficiency.
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